New treatments in inflammatory bowel disease - A thrilling time ahead
Gomollón, Fernando (Universidad de Zaragoza)
Resumen: Except for some surgical techniques, up to 1940 the clinical course of inflammatory bowel disease was determined by its own natural history: most medical interventions even worsened prognosis. The empyrical introduction of salazopyrine early in the 1940s, pioneered by Nanna Svartz in Sweden, was followed relatively soon by the incorporation of corticosteroids during the 1950s. However, it took both a long time to reach patients, and quality scientific evidence to better establish their indications built up very slowly.
Idioma: Inglés
DOI: 10.17235/reed.2024.10764/2024
Año: 2024
Publicado en: REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 116, 12 (2024), 657-660
ISSN: 1130-0108
Factor impacto JCR: 4.0 (2024)
Categ. JCR: GASTROENTEROLOGY & HEPATOLOGY rank: 35 / 147 = 0.238 (2024) - Q1 - T1
Factor impacto SCIMAGO: 0.284 - Medicine (miscellaneous) (Q3) - Gastroenterology (Q3)
Tipo y forma: (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you may not distribute the modified material.
Exportado de SIDERAL (2025-09-22-14:45:18)
Visitas y descargas
Idioma: Inglés
DOI: 10.17235/reed.2024.10764/2024
Año: 2024
Publicado en: REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 116, 12 (2024), 657-660
ISSN: 1130-0108
Factor impacto JCR: 4.0 (2024)
Categ. JCR: GASTROENTEROLOGY & HEPATOLOGY rank: 35 / 147 = 0.238 (2024) - Q1 - T1
Factor impacto SCIMAGO: 0.284 - Medicine (miscellaneous) (Q3) - Gastroenterology (Q3)
Tipo y forma: (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you may not distribute the modified material. Exportado de SIDERAL (2025-09-22-14:45:18)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Medicina
Record created 2025-01-15, last modified 2025-09-23